Patients in the RADIANCE-HTN SOLO trial who crossed over from the sham-control arm and were treated with ultrasound-based renal denervation saw a similar lowering of blood pressure to patients who were assigned to the renal denervation arm, according to a post hoc analysis of the trial presented Friday at the PCR e-Course.